Follow
Dr. Sushil Kumar Kashaw
Dr. Sushil Kumar Kashaw
Dr. Harisingh Gour Central University, Sagar-M.P., India
Verified email at dhsgsu.edu.in - Homepage
Title
Cited by
Cited by
Year
PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome
HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise, SK Kashaw, AK Iyer
Frontiers in pharmacology 8, 561, 2017
12852017
Recent developments and biological activities of thiazolidinone derivatives: A review
AK Jain, A Vaidya, V Ravichandran, SK Kashaw, RK Agrawal
Bioorganic & medicinal chemistry 20 (11), 3378-3395, 2012
4442012
siRNA delivery strategies: a comprehensive review of recent developments
K Tatiparti, S Sau, SK Kashaw, AK Iyer
Nanomaterials 7 (4), 77, 2017
3342017
CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1, 3, 4-thiadiazole-2-yl]-2-styryl quinazoline-4 (3H)-ones
V Jatav, P Mishra, S Kashaw, JP Stables
European journal of medicinal chemistry 43 (9), 1945-1954, 2008
3102008
Synthesis and CNS depressant activity of some novel 3-[5-substituted 1, 3, 4-thiadiazole-2-yl]-2-styryl quinazoline-4 (3H)-ones
V Jatav, P Mishra, S Kashaw, JP Stables
European journal of medicinal chemistry 43 (1), 135-141, 2008
2232008
Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl/ethyl-4H-quinazolin-3-yl)-urea
SK Kashaw, V Kashaw, P Mishra, NK Jain, JP Stables
European Journal of Medicinal Chemistry 44 (11), 4335-4343, 2009
1662009
Advances in antibody–drug conjugates: A new era of targeted cancer therapy
S Sau, HO Alsaab, SK Kashaw, K Tatiparti, AK Iyer
Drug Discovery Today 22 (10), 1547-1556, 2017
1372017
Synthesis and antimicrobial activity of some new 3–[5-(4-substituted) phenyl-1, 3, 4-oxadiazole-2yl]-2-styrylquinazoline-4 (3H)-ones
V Gupta, SK Kashaw, V Jatav, P Mishra
Medicinal Chemistry Research 17 (2-7), 205-211, 2008
1312008
Comprehensive review on various strategies for antimalarial drug discovery
M Mishra, VK Mishra, V Kashaw, AK Iyer, SK Kashaw
European Journal of Medicinal Chemistry 125, 1300-1320, 2017
1072017
Fabrication of Apigenin loaded gellan gum–chitosan hydrogels (GGCH-HGs) for effective diabetic wound healing
R Shukla, SK Kashaw, AP Jain, S Lodhi
International journal of biological macromolecules 91, 1110-1119, 2016
902016
Synthesis of novel 2, 5‐disubstituted 1, 3, 4‐thiadiazoles for their potential anticonvulsant activity: pharmacophoric model studies
H Rajak, R Deshmukh, N Aggarwal, S Kashaw, MD Kharya, P Mishra
Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2009
892009
Nanostructured lipid carriers employing polyphenols as promising anticancer agents: Quality by design (QbD) approach
K Bhise, SK Kashaw, S Sau, AK Iyer
International journal of pharmaceutics 526 (1-2), 506-515, 2017
812017
Anticonvulsant and sedative-hypnotic activity of some novel 3-[5-(4-substituted) phenyl-1,3,4-oxadiazole-2yl]-2-styrylquinazoline-4(3H)-ones
SK Kashaw, V Gupta, V Kashaw, P Mishra, JP Stables, NK Jain
Medicinal chemistry research 19, 250-261, 2010
802010
Assessment of penetration potential of pH responsive double walled biodegradable nanogels coated with eucalyptus oil for the controlled delivery of 5-fluorouracil: In vitro and …
P Sahu, SK Kashaw, S Jain, S Sau, AK Iyer
Journal of Controlled Release 253, 122-136, 2017
792017
Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers
KA Gawde, S Sau, K Tatiparti, SK Kashaw, M Mehrmohammadi, AS Azmi, ...
Colloids and Surfaces B: Biointerfaces 167, 8-19, 2018
672018
Synthesis of 1, 3, 5-trisubstituted pyrazolines as potential antimalarial and antimicrobial agents
VK Mishra, M Mishra, V Kashaw, SK Kashaw
Bioorganic & Medicinal Chemistry 25 (6), 1949-1962, 2017
562017
pH responsive biodegradable nanogels for sustained release of bleomycin
P Sahu, SK Kashaw, V Kushwah, S Sau, S Jain, AK Iyer
Bioorganic & medicinal chemistry 25 (17), 4595-4613, 2017
552017
Synthesis and anticonvulsant activity of some substituted 1, 2, 4-thiadiazoles
A Gupta, P Mishra, SN Pandeya, SK Kashaw, V Kashaw, JP Stables
European journal of medicinal chemistry 44 (3), 1100-1105, 2009
532009
Nanomedicine for cancer diagnosis and therapy: Advancement, success and structure–activity relationship
K Bhise, S Sau, H Alsaab, SK Kashaw, RK Tekade, AK Iyer
Therapeutic delivery 8 (11), 1003-1018, 2017
512017
PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome. Front Pharmacol. 2017; 8: 561
HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise, SK Kashaw, AK Iyer
Frontiers Media SA DOI 10, 2017
502017
The system can't perform the operation now. Try again later.
Articles 1–20